{"id":"https://openalex.org/W3036613613","doi":"https://doi.org/10.36849/jdd.2020.3679","title":"Rosacea Treatment Satisfaction: Matching Adjusted Indirect Treatment Comparison Analysis of Metronidazole Gel or Cream vs Azelaic Acid Foam","display_name":"Rosacea Treatment Satisfaction: Matching Adjusted Indirect Treatment Comparison Analysis of Metronidazole Gel or Cream vs Azelaic Acid Foam","publication_year":2020,"publication_date":"2020-02-01","ids":{"openalex":"https://openalex.org/W3036613613","doi":"https://doi.org/10.36849/jdd.2020.3679","mag":"3036613613","pmid":"https://pubmed.ncbi.nlm.nih.gov/32550696"},"language":"en","primary_location":{"id":"doi:10.36849/jdd.2020.3679","doi":"https://doi.org/10.36849/jdd.2020.3679","is_oa":false,"landing_page_url":"https://doi.org/10.36849/jdd.2020.3679","pdf_url":null,"source":{"id":"https://openalex.org/S111565304","display_name":"Journal of Drugs in Dermatology","issn_l":"1545-9616","issn":["1545-9616"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4323285840","host_organization_name":"SanovaWorks","host_organization_lineage":["https://openalex.org/P4323285840"],"host_organization_lineage_names":["SanovaWorks"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Drugs in Dermatology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090209969","display_name":"Todd E Williamson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Todd Williamson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022792046","display_name":"Anneliese LaRose","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anneliese LaRose","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Jennifer Cameron","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer Cameron","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058831086","display_name":"Jason P. Lott","orcid":"https://orcid.org/0000-0002-4097-7225","observed_orcids":["https://orcid.org/0000-0002-4097-7225"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jason Lott","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066102500","display_name":"Michael T. Eaddy","orcid":"https://orcid.org/0000-0002-2896-8721","observed_orcids":["https://orcid.org/0000-0002-2896-8721"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Eaddy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051142765","display_name":"Sari D. Hopson","orcid":"https://orcid.org/0000-0002-9835-0839","observed_orcids":["https://orcid.org/0000-0002-9835-0839"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sari Hopson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069869047","display_name":"Huai-Che Shih","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Huai-Che Shih","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5048898264","display_name":"Linnea Tennan Tennant","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Linnea Tennan Tennant","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.10632611,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"19","issue":"3","first_page":"295","last_page":"304"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11306","display_name":"Nonmelanoma Skin Cancer Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rosacea","display_name":"rosacea","score":0.9890000224113464},{"id":"https://openalex.org/keywords/metronidazole-gel","display_name":"metronidazole gel","score":0.8769999742507935},{"id":"https://openalex.org/keywords/treatment-satisfaction","display_name":"treatment satisfaction","score":0.8500000238418579},{"id":"https://openalex.org/keywords/treatment-side-effects","display_name":"treatment side effects","score":0.8330000042915344},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.7239999771118164},{"id":"https://openalex.org/keywords/treatment-tolerability","display_name":"treatment tolerability","score":0.7879999876022339},{"id":"https://openalex.org/keywords/dryness","display_name":"dryness","score":0.5699999928474426}],"concepts":[{"id":"https://openalex.org/C2778081122","wikidata":"https://www.wikidata.org/wiki/Q831530","display_name":"Rosacea","level":3,"score":0.9759950637817383},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9433133006095886},{"id":"https://openalex.org/C2777396551","wikidata":"https://www.wikidata.org/wiki/Q169569","display_name":"Metronidazole","level":3,"score":0.8275543451309204},{"id":"https://openalex.org/C2780285341","wikidata":"https://www.wikidata.org/wiki/Q413504","display_name":"Azelaic acid","level":2,"score":0.666195273399353},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5872474908828735},{"id":"https://openalex.org/C2777673923","wikidata":"https://www.wikidata.org/wiki/Q79928","display_name":"Acne","level":2,"score":0.3746052384376526},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.11689361929893494},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.08466744422912598},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008795","descriptor_name":"Metronidazole","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008795","descriptor_name":"Metronidazole","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008795","descriptor_name":"Metronidazole","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D008795","descriptor_name":"Metronidazole","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012393","descriptor_name":"Rosacea","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017060","descriptor_name":"Patient Satisfaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.36849/jdd.2020.3679","doi":"https://doi.org/10.36849/jdd.2020.3679","is_oa":false,"landing_page_url":"https://doi.org/10.36849/jdd.2020.3679","pdf_url":null,"source":{"id":"https://openalex.org/S111565304","display_name":"Journal of Drugs in Dermatology","issn_l":"1545-9616","issn":["1545-9616"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4323285840","host_organization_name":"SanovaWorks","host_organization_lineage":["https://openalex.org/P4323285840"],"host_organization_lineage_names":["SanovaWorks"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Drugs in Dermatology","raw_type":"journal-article"},{"id":"pmid:32550696","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32550696","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3005489625","https://openalex.org/W2094101007","https://openalex.org/W2033301840","https://openalex.org/W1992681571","https://openalex.org/W2792159314","https://openalex.org/W1967047209","https://openalex.org/W2430304552","https://openalex.org/W116510131","https://openalex.org/W192147334","https://openalex.org/W99271327"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"assess":[2],"differences":[3],"in":[4,70,269],"patient-reported":[5,36],"treatment":[6,99,109,119,138,240,262,281],"side":[7,54,67,110,182,202,227,243,252,290],"effects":[8,55,183,203,228,244,253,291],"and":[9,22,53,56,63,76,108,124,145,169,189,196,213,219,234,242,248,283],"concerns":[10,52,62,97,117,134,160,241,279],"associated":[11,157],"with":[12,98,118,135,140,158,167,259,272,280,295],"azelaic":[13],"acid":[14],"15%":[15],"foam":[16],"(AAF)":[17],"vs":[18,74,78,102,106,122,127,143,148,187,194,207,211,216],"metronidazole":[19,23],"cream":[20],"(MC)":[21],"gel":[24],"(MG).":[25],"METHODS:":[26],"This":[27],"study":[28],"used":[29],"matching-adjusted":[30],"indirect":[31],"comparison":[32],"(MAIC)":[33],"to":[34,90,174,289],"compare":[35],"outcomes":[37],"from":[38],"survey":[39],"data":[40],"evaluating":[41],"rosacea":[42],"treatments.":[43],"Outcomes":[44],"of":[45,49,58,60,65,137,155,184,204,250],"interest":[46],"included":[47],"percentages":[48],"patients":[50,93,113,130,151,165,178,198,221,236,257,270,275,293],"reporting":[51,152],"measures":[57],"importance":[59,156],"the":[61,66],"tolerability":[64,249],"effects.":[68,111],"Patients":[69],"each":[71],"analysis":[72],"(MG":[73],"AAF":[75],"MC":[77,146,297],"AAF)":[79],"were":[80],"matched":[81],"using":[82],"stabilized":[83],"inverse":[84],"propensity":[85],"scores.":[86],"RESULTS:":[87],"When":[88,172],"compared":[89,139,166,173],"AAF,":[91,273],"MG-treated":[92,177],"more":[94,114,131,179,199,237,266],"frequently":[95,115,132,180,200,238,277],"reported":[96,116,133,181,201,226,239,278,284],"efficacy":[100,120,282],"(54%":[101],"4%),":[103],"application":[104],"(7%":[105,142,206,210,215],"3%),":[107,208],"MC-treated":[112,170,197,220,235],"(61%":[121],"5%)":[123],"dryness":[125,185],"(8%":[126],"5%).":[128,217],"AAF-treated":[129,164,175,230,246],"cost":[136,263],"MG":[141],"1%)":[144],"(9%":[147],"4%).":[149],"Among":[150],"concerns,":[153],"level":[154],"these":[159,274],"was":[161,254],"similar":[162,285],"for":[163,225,256],"MG-":[168,218,233],"patients.":[171,231],"patients,":[176,247],"(26%":[186],"15%)":[188],"uneven":[190],"skin":[191],"tone":[192],"(3%":[193],"0%),":[195],"burning":[205],"itching":[209],"5%),":[212],"redness":[214],"indicated":[222],"greater":[223,287],"intolerance":[224],"than":[229,245,292],"CONCLUSIONS:":[232],"those":[251],"higher":[255],"treated":[258,271,294],"AAF.":[260],"While":[261],"is":[264],"a":[265],"frequent":[267],"concern":[268],"less":[276],"or":[286,298],"tolerance":[288],"either":[296],"MG.":[299],"J":[300],"Drugs":[301],"Dermatol.":[302],"2020;19(3):":[303],"doi:10.36849/JDD.2020.3679.":[304]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2020-06-25T00:00:00"}